Cymabay Therapeutics (CBAY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -72,548 | -27,557 | -26,671 | -15,529 | -31,917 |
| Depreciation Amortization | -1,840 | -164 | 154 | 533 | 471 |
| Accounts receivable | 5,000 | -5,000 | N/A | N/A | -101 |
| Accounts payable and accrued liabilities | 662 | 412 | -109 | -1,077 | 1,388 |
| Other Working Capital | 8,859 | -3,041 | 290 | 78 | 1,604 |
| Other Operating Activity | 4,931 | 15,718 | 2,983 | -7,329 | 7,441 |
| Operating Cash Flow | $-54,936 | $-19,632 | $-23,353 | $-23,324 | $-21,114 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -53,582 | -67,501 | 27,170 | -11,083 | -16,835 |
| PPE Investments | -529 | -27 | -42 | N/A | -103 |
| Investing Cash Flow | $-54,111 | $-67,528 | $27,128 | $-11,083 | $-16,938 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 9,482 | N/A |
| Debt Repayment | -6,653 | -3,137 | -986 | -4,756 | -244 |
| Common Stock Issued | 141,641 | 102,856 | N/A | 25,801 | 25,481 |
| Financing Cash Flow | $134,988 | $99,719 | $-986 | $30,527 | $25,237 |
| Beginning Cash Position | 23,054 | 10,495 | 7,706 | 11,586 | 24,401 |
| End Cash Position | 48,995 | 23,054 | 10,495 | 7,706 | 11,586 |
| Net Cash Flow | $25,941 | $12,559 | $2,789 | $-3,880 | $-12,815 |
| Free Cash Flow | |||||
| Operating Cash Flow | -54,936 | -19,632 | -23,353 | -23,324 | -21,114 |
| Capital Expenditure | -529 | -27 | -42 | N/A | -103 |
| Free Cash Flow | -55,465 | -19,659 | -23,395 | -23,324 | -21,217 |